Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms

Abstract Background Oxytocin is expected as a novel therapeutic agent for autism spectrum disorder (ASD) core symptoms. However, previous results on the efficacy of repeated administrations of oxytocin are controversial. Recently, we reported time-course changes in the efficacy of the neuropeptide u...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yasuhiko Kato, Hitoshi Kuwabara, Takashi Okada, Toshio Munesue, Seico Benner, Miho Kuroda, Masaki Kojima, Walid Yassin, Yosuke Eriguchi, Yosuke Kameno, Chihiro Murayama, Tomoko Nishimura, Kenji Tsuchiya, Kiyoto Kasai, Norio Ozaki, Hirotaka Kosaka, Hidenori Yamasue
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2021-02-01
Col·lecció:	Molecular Autism
Matèries:	Asperger Autism Clinical trial Developmental disorders Facial expression Metabolomics
Accés en línia:	https://doi.org/10.1186/s13229-021-00423-z
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!